Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

8049
Current price
1.45 HKD 0 HKD (0.00%)
Last closed 1.42 HKD
ISIN CNE100000130
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 807 527 192 HKD
Yield for 12 month +16.00 %
1Y
3Y
5Y
10Y
15Y
8049
21.11.2021 - 28.11.2021

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers Edaravone injection, compound brain comfort capsules, haikun kidney hi capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine glucosa tablets, prostate laurel yellow tablets, tranquility tablets, pharyngitis tablets, and low back pain capsules. The company markets its products under the Changlong and Qing Tong brands. It also engages in the manufacture and distribution of beverages and prepackaged food. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong. Address: Grand Plaza, Office Tower Two, Kowloon, Hong Kong

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

4.3939

Dividend Yield

4.71 %

Current Year

+918 183 764 HKD

Last Year

+918 228 498 HKD

Current Quarter

+271 355 436 HKD

Last Quarter

+215 162 101 HKD

Current Year

+637 234 558 HKD

Last Year

+707 050 977 HKD

Current Quarter

+188 001 029 HKD

Last Quarter

+158 979 679 HKD

Key Figures 8049

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 204 956 798 HKD
Operating Margin TTM 32.51 %
PE Ratio 4.3939
Return On Assets TTM 4.83 %
PEG Ratio
Return On Equity TTM 10.77 %
Wall Street Target Price
Revenue TTM 839 800 169 HKD
Book Value 2.83 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -22.3 %
Dividend Yield 4.71 %
Gross Profit TTM 580 556 788 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 83.2 %
Profit Margin 20.46 %

Dividend Analytics 8049

Dividend growth over 5 years

546 %

Continuous growth

1 year

Payout Ratio 5 years average

44 %

Dividend History 8049

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 18.06.2024
Forward Annual Dividend Yield 4.73 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 8049

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 4.3939
Forward PE
Enterprise Value Revenue 0.2185
Price Sales TTM 0.9616
Enterprise Value EBITDA 0.8351
Price Book MRQ 0.4703

Financials 8049

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 8049

For 52 weeks

1.16 HKD 1.86 HKD
50 Day MA 1.4 HKD
Shares Short Prior Month
200 Day MA 1.54 HKD
Short Ratio
Shares Short
Short Percent